Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04118998 · ClinicalTrials.gov registry record · NA
Progressive Abduction Loading Therapy
A NA study of Stroke, Acute, sponsored by Northwestern University.
- Active
- Registry status
- NA
- Development phase
- 86
- Enrollment target
- 3
- Study locations
NCT04118998: Active NA study of Stroke, Acute, sponsored by Northwestern University.
NCT04118998 is a NA study of Stroke, Acute that is active but no longer recruiting, run by Northwestern University. The registered enrollment target is 86 participants, below the 627-participant average among 25 other Stroke, Acute trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04118998, a NA study of Stroke, Acute, is active but no longer recruiting, sponsored by Northwestern University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 86 participants
- Enrollment target
- 3
- Study locations
Study Summary
This study attempts to minimize the development of a common movement impairment following stroke known as "flexion synergy" that makes it extremely difficult to reach outward with the arm. Participants with acute/subacute stroke will receive one of two study interventions in addition to prescribed therapies in both inpatient rehabilitation and day-rehab. Participants will be followed for 1 year.
Primary Outcome
Quantitative evaluation of reaching by calculating distance from reaching kinematics data during ballistic outward reaches against gravity.
Conditions Studied
Interventions
- BEHAVIORAL Abduction Loading
- BEHAVIORAL Supported Reaching
Study Locations (3)
Illinois
- Department of Physical Therapy and Human Movement Sciences - Chicago
- Shirley Ryan AbilityLab - Chicago
- Northwestern Medicine Marianjoy Rehabilitation Hospital - Wheaton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 86 participants |
| Start Date | 2021-08-27 |
| Est. Completion | 2026-08-31 |
| Phase | NA |
What the registry record for NCT04118998 still lists
NCT04118998 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 86 participants, a relatively small participant target, below the 627-participant average among 25 other Stroke, Acute trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Stroke, Acute appearing as the primary indexed condition, and to 2 interventions - of which Abduction Loading is the first listed.
NCT04118998 reports a single indexed study location in Illinois.
Frequently Asked Questions
What is clinical trial NCT04118998 about?
NCT04118998 is a clinical study titled "Progressive Abduction Loading Therapy". This study attempts to minimize the development of a common movement impairment following stroke known as "flexion synergy" that makes it extremely difficult to reach outward with the arm. Participants with acute/subacute stroke will receive one of two study interventions in addition to prescribed t...
What is the current status of trial NCT04118998?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 86 participants. The study started on 2021-08-27. Estimated completion is 2026-08-31.
What conditions does trial NCT04118998 study?
This clinical trial studies the following conditions: Stroke, Acute.
What interventions are being tested in trial NCT04118998?
The interventions under investigation include: Abduction Loading (BEHAVIORAL), Supported Reaching (BEHAVIORAL).
Who is sponsoring clinical trial NCT04118998?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04118998 being conducted?
This trial has 3 study locations across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stroke, Acute
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04118998's enrollment target sits among peer trials
86 21st of 25 higher than 5 of 25 other Stroke, Acute trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stroke, Acute trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
WE-TRUST (Workflow Optimization to Reduce Time to Endovascular Reperfusion for Ultra-fast Stroke Treatment)
RECRUITING · NA
-
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
RECRUITING · NA
-
Delay AvoIding Primary Evaluation for ThRombectomy of Acute StrokE Patients With Large Vessel OCclusion in the Angiography SuiTe
RECRUITING · NA
-
Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition
RECRUITING · NA
-
Efficacy of a Telehealth Delivered Group Lifestyle Balance for People Post Stroke (tGLB-CVA)
RECRUITING · NA
-
ECMO ABI Detection With Hyperfine
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01639508 · 86 participants · Phase 2
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
- NCT03519269 · 86 participants · NA
Navio Robotic Versus Conventional Total Knee Arthroplasty
- NCT04132999 · 86 participants · NA
PAP for Children With DS and OSAS
- NCT04545957 · 86 participants · NA
Jump: MR Simulation For Radiation Therapy Master Protocol
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI